We have screened 76 DMD and 5 BMD patients for deletions, using two se
parate Multiplex gene amplification systems. The use of both systems t
ogether revealed deletions in 52% of the cases in the Turkish populati
on. The majority of these deletions (33/37) were found to be localized
within the central region of the dystrophin gene. The remaining delet
ions were mapped to the proximal hotspot. Deletion end-points were ide
ntified by PCR and/or by Southern blot analysis with cDNA probes, and
exceptions to the Open Reading Frame (ORF) hypothesis are discussed. P
CR-based techniques to screen the pERT87.15/XmnI, pERT87.15/BamHI, and
pERT87.8/TaqI polymorphisms were used for linkage analysis in the Tur
kish DMD/BMD families, and approximately 70% of the mothers at risk we
re found to be informative for at least one of these polymorphisms stu
died.